NCT05906199View on ClinicalTrials.gov

A Study to Compare the Effects of Improving the Carotid Artery Intima Media Thickness and Changing Lipid Levels by Cilostazol/Ginkgo Leaf Extract and Aspirin in Diabetic Peripheral Angiopathy.

PHASE4CompletedINTERVENTIONAL

Enrollment

105

Participants

Timeline

Start Date

July 28, 2021

Primary Completion Date

June 23, 2023

Study Completion Date

December 13, 2023

Conditions

Diabetic Peripheral Angiopathy

Interventions

DRUG

Renexin CR 200/160mg

Single oral administration of Renexin CR 200/160mg, QD

DRUG

Aspirin 100mg

Single oral administration of Aspirin 100mg, QD

Trial Locations (2)

Unknown

SKChemicals, Seongnam

110-744

SK chemicals, Seoul

All Listed Sponsors

lead

SK Chemicals Co., Ltd.

INDUSTRY

NCT05906199 - A Study to Compare the Effects of Improving the Carotid Artery Intima Media Thickness and Changing Lipid Levels by Cilostazol/Ginkgo Leaf Extract and Aspirin in Diabetic Peripheral Angiopathy. | Biotech Hunter | Biotech Hunter